Access to High Cost Medicines in Australia: Ethical Perspectives

Australia and New Zealand Health Policy
doi 10.1186/1743-8462-5-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Orphan Medicines: The High Cost of Hope

Prescriber
Pharmacology
2018English

Access to Essential Medicines in National Constitutions

Bulletin of the World Health Organization
EnvironmentalPublic HealthOccupational Health
2010English

TheSocialMedwork: Providing Access to Overseas Medicines

Prescriber
Pharmacology
2019English

Access to Medicines—business as Usual?

The Lancet Global Health
Medicine
2019English

Reforming Canada's Access to Medicines Regime

CMAJ
Medicine
2007English

The Cost-Effectiveness of Dabigatran and the Opportunity Cost of Delayed Subsidised Access in Australia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Access to Medicines Information for Pregnant Women

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2015English

Access to Medicines and European Market Integration

SSRN Electronic Journal
2016English

The European Medicines Agency Facilitates Access to Medicines in Low- And Middle-Income Countries

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy